{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-027280","form_type":"8-K","ticker":"OPY","cik":"0000791963","company_name":"OPPENHEIMER HOLDINGS INC","filed_at":"2026-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.732212+00:00","generated_at":"2026-05-15T04:07:32.884690+00:00","sec_items":["1.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Oppenheimer settles cash-sweep class action for $70M, to impact Q1 earnings","bullets":["Settlement of Liberty Capital Group class action for $70M; plaintiff had sought >$440M in damages.","Payment into escrow 10 days after preliminary court approval, expected within 90 days.","No admission of liability; release covers all claims from 2022 through final approval.","$70M charge to be taken in Q1 2026 earnings (reporting May 1); company expects full tax deductibility.","Settlement avoids jury trial scheduled for June 2026; case was first of ~25 similar suits to go to trial."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-027280","json":"https://secwatch.observer/filing/0001628280-26-027280.json","markdown":"https://secwatch.observer/filing/0001628280-26-027280.md","text":"https://secwatch.observer/filing/0001628280-26-027280.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/opy-20260424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:07:32.884690+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3ccf67051543db2b324bfb8b43c6a60a8c0adf6f","claim":"OPPENHEIMER HOLDINGS INC entered into Settlement Term Sheet with Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated valued at $70 million (effective 2026-04-24).","evidence_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001805651-26-000038","ticker":"MKTW","company_name":"MARKETWISE, INC.","filed_at":"2026-04-24T23:59:59+00:00","headline":"MarketWise settles arbitration with former CEO for $12.16M cash, redeems 520,867 units, terminates TRA rights","event_type":"litigation","sec_items":["1.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001805651-26-000038","json":"https://secwatch.observer/filing/0001805651-26-000038.json","markdown":"https://secwatch.observer/filing/0001805651-26-000038.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1805651/000180565126000038/0001805651-26-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1805651/000180565126000038/mktw-20260421.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"On April 21, 2026, Marketwise, Inc. (the “Company”) and its subsidiary, MarketWise, LLC (together with the Company, “MarketWise”), entered into a Settlement Agreement and Release (the “Settlement Agreement”) with Mark P. Arnold, the Company’s former Chief Executive Officer, and JAMA 2021, LLC (together with Mr. Arnold, the “Arnold Parties”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1805651/000180565126000038/0001805651-26-000038-index.htm"}},{"accession":"0001171843-26-002591","ticker":"AGAE","company_name":"Allied Gaming & Entertainment Inc.","filed_at":"2026-04-21T23:59:59+00:00","headline":"Allied Gaming settles litigation with Knighted for ~$5.94M paid over 3 months; CEO Li personally guarantees payment","event_type":"litigation","sec_items":["1.01","5.02","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-002591","json":"https://secwatch.observer/filing/0001171843-26-002591.json","markdown":"https://secwatch.observer/filing/0001171843-26-002591.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708341/000117184326002591/0001171843-26-002591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708341/000117184326002591/f8k_042026.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"On April 10, 2026, Allied Gaming & Entertainment Inc. (the “Company”) and Yangyang Li, its Chief Executive Officer and Chairman, in his personal capacity (“Mr. Li”, and together with the Company, the “Allied Parties”) entered into a binding Term Sheet for Global Resolution (the “Term Sheet”) with Knighted Pastures, LLC (“Knighted”) and Roy Choi, in his personal capacity (“Mr. Choi”, and together with Knighted, the “Knighted Parties”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1708341/000117184326002591/0001171843-26-002591-index.htm"}},{"accession":"0001140361-26-010656","ticker":"ROIV","company_name":"Roivant Sciences Ltd.","filed_at":"2026-03-23T23:59:59+00:00","headline":"Roivant subsidiary Genevant settles LNP patent litigation with Moderna; includes license and payments","event_type":"litigation","sec_items":["1.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-010656","json":"https://secwatch.observer/filing/0001140361-26-010656.json","markdown":"https://secwatch.observer/filing/0001140361-26-010656.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126010656/0001140361-26-010656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126010656/ef20068452_8ka.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"on March 3, 2026, Genevant, Arbutus and, solely for certain purposes, GSL, entered into a Settlement Agreement with Moderna to resolve all patent infringement litigation between Genevant/Arbutus and Moderna pending in the U.S. and internationally relating to Moderna's use of Genevant/Arbutus’ lipid nanoparticle delivery technology in its vaccines.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126010656/0001140361-26-010656-index.htm"}},{"accession":"0001193125-26-117652","ticker":"OESX","company_name":"ORION ENERGY SYSTEMS, INC.","filed_at":"2026-03-20T23:59:59+00:00","headline":"Orion settles Voltrek earnout dispute for $3M cash; solar PPA exit adds $1.3M offset","event_type":"litigation","sec_items":["1.01","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-117652","json":"https://secwatch.observer/filing/0001193125-26-117652.json","markdown":"https://secwatch.observer/filing/0001193125-26-117652.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1409375/000119312526117652/0001193125-26-117652-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1409375/000119312526117652/oesx-20260317.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"On March 17, 2026, Orion Energy Systems, Inc. and its subsidiaries (collectively, the “ Company ”) entered into a settlement agreement (the “ Settlement Agreement ”) with Final Frontier, LLC (“ Final Frontier ”) and Kathleen M. Connors (“ Ms. Connors ”), personally and as Trustee of the Kathleen M. Connors 2019 Revocable Trust","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1409375/000119312526117652/0001193125-26-117652-index.htm"}},{"accession":"0001193125-26-094084","ticker":"TRNR","company_name":"Interactive Strength, Inc.","filed_at":"2026-03-05T23:59:59+00:00","headline":"TRNR recovers $6.4M in full settlement of Sportstech loan dispute, ends legal proceedings","event_type":"litigation","sec_items":["1.01","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-094084","json":"https://secwatch.observer/filing/0001193125-26-094084.json","markdown":"https://secwatch.observer/filing/0001193125-26-094084.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785056/000119312526094084/0001193125-26-094084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785056/000119312526094084/trnr-20260227.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"On February 27, 2026, the Company and Sportstech entered into a Settlement Agreement (the “Settlement Agreement”), pursuant to which Sportstech was to pay the Company $6,350,000 along with making a payment to the Company’s counsel in its legal dispute with Sportstech (the “Settlement Payment”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785056/000119312526094084/0001193125-26-094084-index.htm"}},{"accession":"0001140361-26-007548","ticker":"ROIV","company_name":"Roivant Sciences Ltd.","filed_at":"2026-03-03T23:59:59+00:00","headline":"Roivant's Genevant/Arbutus settles Moderna LNP patent suit for $950M upfront, plus $1.3B contingent","event_type":"litigation","sec_items":["1.01","7.01","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-007548","json":"https://secwatch.observer/filing/0001140361-26-007548.json","markdown":"https://secwatch.observer/filing/0001140361-26-007548.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126007548/0001140361-26-007548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126007548/ef20067067_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"On March 3, 2026 (the “Effective Date”), Genevant Sciences GmbH (“Genevant”), a subsidiary of Roivant Sciences Ltd. (the “Company” or “Roivant”), Arbutus Biopharma Corp. (together with Genevant, “Genevant/Arbutus”), and, solely for certain purposes, Genevant Sciences Ltd., and Moderna, Inc. and ModernaTx, Inc. (together, “Moderna”) entered into a settlement agreement (the “Settlement Agreement”)","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126007548/0001140361-26-007548-index.htm"}},{"accession":"0001171843-26-001299","ticker":"ABUS","company_name":"Arbutus Biopharma Corp","filed_at":"2026-03-03T23:59:59+00:00","headline":"Arbutus/Genevant settle Moderna LNP patent litigation for $2.25B; $950M upfront due July 2026","event_type":"litigation","sec_items":["1.01","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-001299","json":"https://secwatch.observer/filing/0001171843-26-001299.json","markdown":"https://secwatch.observer/filing/0001171843-26-001299.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447028/000117184326001299/0001171843-26-001299-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447028/000117184326001299/f8k_030326.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"On March 3, 2026 (the “Effective Date”), Arbutus Biopharma Corporation (“Arbutus” or the “Company”), Genevant Sciences GmbH (“Genevant” and together with Arbutus, “Arbutus/Genevant”), and, solely for certain purposes, Genevant Sciences Ltd., and Moderna, Inc. and ModernaTx, Inc. (together, “Moderna”) entered into a settlement agreement (the “Settlement Agreement”) to resolve all patent infringement litigation between Arbutus/Genevant and Moderna pending in the U.S. and internationally relating to Moderna’s unauthorized use of Arbutus/Genevant’s lipid nanoparticle (“LNP”) delivery technology in its vaccines, including Spikevax® (the “LNP Litigation”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1447028/000117184326001299/0001171843-26-001299-index.htm"}},{"accession":"0001437749-26-015945","ticker":"ICCC","company_name":"IMMUCELL CORP /DE/","filed_at":"2026-05-08T23:59:59+00:00","headline":"ImmuCell settles Norbrook dispute, to receive $2M payment","event_type":"litigation","sec_items":["1.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-015945","json":"https://secwatch.observer/filing/0001437749-26-015945.json","markdown":"https://secwatch.observer/filing/0001437749-26-015945.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/811641/000143774926015945/0001437749-26-015945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811641/000143774926015945/iccc20260508_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","comparable_excerpt":"On May 8, 2026, ImmuCell Corporation and Norbrook Laboratories Limited (incorporated and registered in Northern Ireland) entered into a Settlement Deed to resolve and release any and all claims arising out of or relating to an underlying 2019 Development Services and Commercial Supply Agreement between the two companies.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000143774926015945/0001437749-26-015945-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}